Nova Biomedical Executive and Leadership Team

Francis Manganaro, the Chief Executive Officer at Nova Biomedical, directs the company's overarching strategic vision and operational execution. Manganaro guides the development and commercialization of advanced analytical instruments and consumables, focusing on the biopharmaceutical and clinical markets. Overseeing the company's commitment to innovation in in vitro diagnostic devices, Manganaro ensures Nova Biomedical maintains its leadership in critical care blood gas analyzers, point-of-care meters, and cell culture monitoring systems. This leadership role involves fostering a culture of technological advancement and customer-centric service, directly impacting the company's global presence and its mission to enhance patient care and accelerate biopharmaceutical development. Francis Manganaro's strategic direction solidifies the company's position as a key player in the medical device industry.

Byron Selman, the President & Chief Executive Officer at Nova Biomedical, spearheads the company's strategic initiatives and global operations. Selman drives the expansion and refinement of Nova Biomedical's portfolio of advanced analytical instruments and consumables, crucial for both biopharmaceutical research and clinical diagnostics. Under Selman's leadership, the company continues its focus on developing innovative in vitro diagnostic devices, including critical care blood gas analyzers and point-of-care meters, enhancing diagnostic accuracy and speed. Byron Selman ensures the company's commitment to accelerating biopharmaceutical development and improving patient care is met through technological excellence and robust commercialization strategies. This executive's vision guides the company's global reach and its dedication to providing cutting-edge solutions in the medical device sector.

Louise Borrelli, the Senior Vice President & Chief Financial Officer at Nova Biomedical, manages the company's financial health and strategic fiscal planning. Borrelli oversees all financial operations, including budgeting, forecasting, and capital allocation, ensuring resources are effectively deployed to support the development and commercialization of advanced analytical instruments and consumables. This role is critical in maintaining the company's financial stability as it innovates in the biopharmaceutical and clinical markets. Louise Borrelli's financial acumen supports the company's global expansion and its commitment to enhancing patient care through cutting-edge technology. By guiding fiscal strategy, Borrelli ensures Nova Biomedical can continue its investment in critical care blood gas analyzers and point-of-care meters, solidifying its market position.

Michelle Buonopane, the Chief Human Resources Officer at Nova Biomedical, directs the company's human capital strategy and organizational development. Buonopane is responsible for cultivating a high-performance culture that supports innovation in the development and commercialization of advanced analytical instruments and consumables for the biopharmaceutical and clinical markets. This leadership position ensures that Nova Biomedical attracts, retains, and develops top talent essential for advancing its mission. Michelle Buonopane's focus on employee engagement and talent management is vital for sustaining the company's commitment to cutting-edge technology and customer service. By optimizing the workforce, Buonopane directly contributes to the company's ability to enhance patient care and accelerate biopharmaceutical development globally.